RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Obalon Therapeutics Stock

Obalon Therapeutics ROA 2024

Obalon Therapeutics ROA

0

Ticker

OBLN

ISIN

US67424L2097

WKN

A2PPB1

In 2024, Obalon Therapeutics's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.

Obalon Therapeutics Aktienanalyse

What does Obalon Therapeutics do?

Obalon Therapeutics Inc is an American company specializing in the development and marketing of innovative medical products for weight reduction. The company is headquartered in Carlsbad, California and was founded in 2008. Its business model is based on the idea that non-invasive weight reduction using balloon technology has advantages over other diets. Obalon aims to help people reduce and maintain their weight in a healthy way. The company's first product, the Obalon Balloon, was approved by the FDA in 2016. In addition to the Obalon Balloon, the company has developed other products over the years, including a gastric balloon system for children and teenagers. Obalon is also internationally active, with offices in Europe and Asia. The company works closely with doctors, hospitals, and weight management experts to distribute and develop its products. Overall, Obalon has experienced impressive growth in recent years and is well positioned to continue growing in the future due to its innovative technology, strong product portfolio, and global presence. Obalon Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Obalon Therapeutics's Return on Assets (ROA)

Obalon Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Obalon Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Obalon Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Obalon Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Obalon Therapeutics stock

What is the Return on Assets (ROA) of Obalon Therapeutics this year?

The Return on Assets (ROA) of Obalon Therapeutics is 0 undefined this year.

What was the ROA of Obalon Therapeutics compared to the previous year?

The ROA of Obalon Therapeutics has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Obalon Therapeutics?

A high ROA is advantageous for investors of Obalon Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Obalon Therapeutics?

A low ROA can be unfavorable for investors of Obalon Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Obalon Therapeutics affect the company?

An increase in ROA of Obalon Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Obalon Therapeutics impact the company?

A reduction in the ROA of Obalon Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Obalon Therapeutics?

Some factors that can influence the ROA of Obalon Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Obalon Therapeutics important for investors?

The ROA of Obalon Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Obalon Therapeutics take to improve ROA?

To improve ROA, Obalon Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Obalon Therapeutics pay?

Over the past 12 months, Obalon Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Obalon Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Obalon Therapeutics?

The current dividend yield of Obalon Therapeutics is .

When does Obalon Therapeutics pay dividends?

Obalon Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Obalon Therapeutics?

Obalon Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Obalon Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Obalon Therapeutics located?

Obalon Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Obalon Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Obalon Therapeutics from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Obalon Therapeutics pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Obalon Therapeutics in the year 2023?

In the year 2023, Obalon Therapeutics distributed 0 USD as dividends.

In which currency does Obalon Therapeutics pay out the dividend?

The dividends of Obalon Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Obalon Therapeutics

Our stock analysis for Obalon Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Obalon Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.